Hypericin in the Dark: Foe or Ally in Photodynamic Therapy?

Photosensitizers (PSs) in photodynamic therapy (PDT) are, in most cases, administered systemically with preferential accumulation in malignant tissues; however, exposure of non-malignant tissues to PS may also be clinically relevant, when PS molecules affect the pro-apoptotic cascade without illumin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huntosova, Veronika, Stroffekova, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082383/
https://www.ncbi.nlm.nih.gov/pubmed/27754424
http://dx.doi.org/10.3390/cancers8100093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082383/
https://www.ncbi.nlm.nih.gov/pubmed/27754424
http://dx.doi.org/10.3390/cancers8100093

Ejemplares similares